Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Essential Hypertension”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00710372
What this trial is testing

Safety, Tolerability and Efficacy of a Vaccine Against Essential Hypertension

Who this might be right for
Mild Essential HypertensionModerate Essential Hypertension
Cytos Biotechnology AG 83
Testing effectiveness (Phase 2)Study completedNCT00759551
What this trial is testing

Efficacy and Safety of Azilsartan in Subjects With Essential Hypertension

Who this might be right for
Hypertension
Takeda 555
Testing effectiveness (Phase 2)Study completedNCT03756103
What this trial is testing

Safety and Efficacy of SPH3127 on Treating Mild-moderate Essential Hypertension Patients

Who this might be right for
Hypertension,Essential
Shanghai Pharmaceuticals Holding Co., Ltd 120
Large-scale testing (Phase 3)Study completedNCT01631227
What this trial is testing

Comparison of the Effect of Eprosartan and Eprosartan Mesylate on Blood Pressure in Essential Hypertension

Who this might be right for
Essential Hypertension
Abbott 665
Large-scale testing (Phase 3)Study completedNCT00250562
What this trial is testing

A Study in Chinese Mild to Moderate Hypertensive Patients Comparing the Efficacy of Co-Diovan With Diovan.

Who this might be right for
Hypertension
Novartis 1,171
Large-scale testing (Phase 3)Study completedNCT00344110
What this trial is testing

Study Comparing SPP100 (Aliskiren) 150mg to Placebo and to Losartan 50mg in Patients With Mild to Moderate Essential Hypertension

Who this might be right for
Hypertension
Novartis 768
Post-approval studies (Phase 4)Study completedNCT00302705
What this trial is testing

Comparison of the Antihypertensive Efficacy of Valsartan and Enalapril After Missing One Dose

Who this might be right for
Hypertension
University of Vigo 150
Testing effectiveness (Phase 2)Study completedNCT01878201
What this trial is testing

A Valsartan 80 Mg-Referenced, Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan 30 mg During 24 Hours in Patients With Mild to Moderate Essential Hypertension

Who this might be right for
Essential Hypertension
Boryung Pharmaceutical Co., Ltd 75
Not applicableStudy completedNCT02336607
What this trial is testing

The Effects on Blood Pressure Control, Pulse Wave Velocity, as Well as Safety and Tolerability of Felodipine Sustained Release in Chinese Patients.

Who this might be right for
Hypertension
AstraZeneca 529
Large-scale testing (Phase 3)Study completedNCT00856271
What this trial is testing

Olmesartan Medoxomil Versus Losartan Potassium in Patients With Mild to Moderate Essential Hypertension

Who this might be right for
Essential Hypertension
Daiichi Sankyo 287
Large-scale testing (Phase 3)UnknownNCT01956786
What this trial is testing

Efficacy of Amlodipine-Folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine

Who this might be right for
Essential Hypertension
Shenzhen Ausa Pharmed Co.,Ltd 540
Large-scale testing (Phase 3)Study completedNCT00220220
What this trial is testing

Amlodipine as add-on to Olmesartan in Hypertension

Who this might be right for
Essential Hypertension
Sankyo Pharma Gmbh 429
Testing effectiveness (Phase 2)Ended earlyNCT01373086
What this trial is testing

LFF269 Compared to Placebo After Treatment in Subjects With Essential Hypertension

Who this might be right for
Hypertension
Novartis Pharmaceuticals 19
Large-scale testing (Phase 3)UnknownNCT01848873
What this trial is testing

Efficacy of Amlodipine-folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine

Who this might be right for
Essential Hypertension
Shenzhen Ausa Pharmed Co.,Ltd 756
Testing effectiveness (Phase 2)Study completedNCT01281306
What this trial is testing

An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension

Who this might be right for
Systolic Hypertension
Novartis Pharmaceuticals 910
Large-scale testing (Phase 3)Study completedNCT02206659
What this trial is testing

Effects of Telmisartan by Ambulatory Blood Pressure Monitoring (ABPM) in Chinese Patients With Mild to Moderate Essential Hypertension

Who this might be right for
Hypertension
Boehringer Ingelheim 20
Post-approval studies (Phase 4)Study completedNCT01431508
What this trial is testing

Safety and Efficacy in MK-0954A Combination in Participants With Hypertension (MK-0954A-373 AM3)

Who this might be right for
Hypertension
Organon and Co 15
Post-approval studies (Phase 4)Study completedNCT01042392
What this trial is testing

Efficacy of Aliskiren Compared to Ramipril in the Treatment of Moderate Systolic Hypertensive Patients

Who this might be right for
Essential Hypertension
Novartis 506
Large-scale testing (Phase 3)Study completedNCT01033071
What this trial is testing

Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Moderate to Severe Hypertension.

Who this might be right for
Essential Hypertension
Takeda 1,071
Post-approval studies (Phase 4)Study completedNCT00311155
What this trial is testing

Olmesartan and an add-on Treatment in Patients With Mild to Moderate Hypertension

Who this might be right for
Essential Hypertension
Sankyo Pharma Gmbh 694
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation